199
Participants
Start Date
November 30, 2013
Primary Completion Date
August 31, 2015
Study Completion Date
August 31, 2015
Ranibizumab
"Intravitreal Injection supplied as:~* 10 mg/mL in a 0.2 mL vial with instructions on preparation and administration of the 0.5 mg (0.05 mL) dose.~* 6 mg/mL in a single use vial with instructions on preparation and administration of the 0.3 mg (0.05 mL) dose.~* Adminstered once a month for 12 weeks"
Placebo
"Oral Placebo is provided in tablet form to match the 50mg dose of PF-04634817.~Dose is 4 tablets each day for 12 weeks"
PF-04634817
Four 50mg tablets PF-04634817 once a day for 12 weeks.
Masked Sham Therapy
Empty, needle-less syringe is used by the unmasked team once a month.
Semmelweis Egyetem, Szemészeti Klinika, Budapest
Bajcsy-Zsilinszky Korhaz, Szemeszet, Budapest
Budapest Retina Associates Kft., Budapest
MC Comac Medical, Sofia
Debreceni Egyetem Orvos- es Egeszsegtudomanyi Centrum, Szemklinika, Debrecen
Ganglion Orvosi Kozpont, Pécs
Csolnoky Ferenc Korhaz, Szemeszeti Osztaly, Veszprém
Fakultni nemocnice Kralovske Vinohrady, Oftalmologicka klinika, Prague
Fakultni nemocnice Kralovske Vinohrady, Ustavni lekarna, Prague
Charite - Universitaetsmedizin Berlin, Campus Benjamin Franklin, Berlin
Associates in Ophthalmology Ltd, West Mifflin
Retina Vitreous Consultants, Pittsburgh
Charlotte Eye Ear Nose and Throat Associates PA, Charlotte
Southeast Retina Center, PC, Augusta
Bascom Palmer Eye Institute, Miami
Fort Lauderdale Eye Institute, Plantation
Center for Retina and Macular Disease, Winter Haven
Universitaetsmedizin Goettingen, Göttingen
Retina Associates of Cleveland, Inc., Cleveland
Meir Medical Center, Kfar Saba
Retina Associates of Cleveland, Youngstown
Midwest Eye Institute, Indianapolis
Wm Beaumont Medical Office Building, Royal Oak
Augenärzte am St. Franziskus-Hospital, Münster
Universitaetsklinikum Muenster, Münster
Rabin Medical Center, Beilinson Hospital, Petah Tikva
TLC Eyecare & Laser Center, Jackson
Fakultní nemocnice Hradec Králové, Nemocnicni lekarna, Hradec Králové
Universitatsmedizin Mainz, Mainz
Black Hills Regional Eye Institute, Rapid City
Tel Aviv Sourasky Medical Center, Tel Aviv
Knappschaftsklinikum GmbH, Sulzbach
Fakultni nemocnice Ostrava, lekarna, Ostrava - Poruba
Fakultni nemocnice Ostrava, Ocni klinika, Ostrava - Poruba
Universitatsklinikum Tubingen, Tübingen
Dean McGee Eye Institute, Oklahoma City
University of Oklahoma -OU Physicians, Oklahoma City
Kaplan Medical Center, Rehovot
Retina Consultants of Houston, PA, Houston
Medical Center Ophthalmology Associates, San Antonio
Brain B.Berger,MD,PA, Austin
Retina Research Center, Austin
Rocky Mountain Retina Consultants, Salt Lake City
Retina Research Institute, LLC, Phoenix
Retinal Consultants of Arizona, Phoenix
Sunny View Medical Center, Phoenix
Premier Research Group Limited, Phoenix
Retina Centers, P.C., Tucson
Retina Vitreous Associates Medical Group, Beverly Hills
American Institute of Research (Administrative Only), Whittier
Retina Institute of California, Arcadia
Hadassah Medical Organization, Hadassah Medical Center, Ein Karem, Jerusalem
Southern California Desert Retina Consultants, Palm Desert
Retina Associates of Orange County, Laguna Hills
Universitätsklinikum Regensburg, Regensburg
Retinal Diagnostic Center, Campbell
New England Retina Associates, New London
Tufts Medical Center, Boston
Fakultní nemocnice Hradec Králové, Ocni klinika, Hradec Králové
Spitalul Clinic Republican, Chisinau
Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza Radeckiego We Wrocławiu, Klinika Okulistyki, Wroclaw
Med Life SA, Sectia Oftalmologie, Bucharest
"Institutul National de Diabet, Nutritie si Boli Metabolice N.C.Paulescu", Bucharest
Lead Sponsor
Pfizer
INDUSTRY